Literature DB >> 27514302

Antidepressants and Suicidality.

David A Brent1.   

Abstract

We review the evidence that antidepressants either increase or decrease the risk for suicidal ideation and behavior in adolescents. Meta-analyses of randomized clinical trials (RCTs) indicate a small increased risk for suicidal events in adolescents and young adults, but a protective effect in older adults. In contrast, pharmacoepidemiologic studies show a protective effect across the life span. Explanations for occurrence of suicidal events in younger patients and for the apparent contradiction between RCT and pharmacoepidemiologic studies are offered. Guidance for clinicians is provided on explaining the risk-benefit ratio of antidepressants and how to monitor and attenuate for suicidal risk.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adolescents; Antidepressant; Clinical trials; Depression; Suicidal events; Suicide; Young adults

Mesh:

Substances:

Year:  2016        PMID: 27514302     DOI: 10.1016/j.psc.2016.04.002

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  13 in total

1.  Adaptation of evidence-based suicide prevention strategies during and after the COVID-19 pandemic.

Authors:  Danuta Wasserman; Miriam Iosue; Anika Wuestefeld; Vladimir Carli
Journal:  World Psychiatry       Date:  2020-10       Impact factor: 49.548

Review 2.  Suicide Risk Assessment and Prevention: Challenges and Opportunities.

Authors:  Eileen P Ryan; Maria A Oquendo
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

3.  Antidepressants and suicide risk in depression.

Authors:  Philppe Courtet; Jorge Lopez-Castroman
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

4.  Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes.

Authors:  Weifen Li; Tahir Ali; Chengyou Zheng; Kaiwu He; Zizhen Liu; Fawad Ali Shah; Ningning Li; Zhi-Jian Yu; Shupeng Li
Journal:  Mol Psychiatry       Date:  2021-10-12       Impact factor: 15.992

5.  Understanding genetic risk factors for common side effects of antidepressant medications.

Authors:  Adrian I Campos; Aoibhe Mulcahy; Jackson G Thorp; Naomi R Wray; Enda M Byrne; Penelope A Lind; Sarah E Medland; Nicholas G Martin; Ian B Hickie; Miguel E Rentería
Journal:  Commun Med (Lond)       Date:  2021-11-09

6.  Circadian Pattern of Deaths Due to Suicide in Intoxicated Alcohol-Dependent Individuals.

Authors:  Subhajit Chakravorty; Rachel V Smith; Michael L Perlis; Michael A Grandner; Henry R Kranzler
Journal:  J Clin Psychiatry       Date:  2018-10-23       Impact factor: 4.384

7.  Using genetic drug-target networks to develop new drug hypotheses for major depressive disorder.

Authors:  Héléna A Gaspar; Zachary Gerring; Christopher Hübel; Christel M Middeldorp; Eske M Derks; Gerome Breen
Journal:  Transl Psychiatry       Date:  2019-03-15       Impact factor: 6.222

Review 8.  Effects of somatic treatments on suicidal ideation and completed suicides.

Authors:  Elise M Hawkins; William Coryell; Stephen Leung; Sagar V Parikh; Cody Weston; Paul Nestadt; John I Nurnberger; Adam Kaplin; Anupama Kumar; Ali A Farooqui; Rif S El-Mallakh
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

9.  Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Authors:  Susanne Stübner; Renate Grohmann; Waldemar Greil; Xueqiong Zhang; Bruno Müller-Oerlinghausen; Stefan Bleich; Eckart Rüther; Hans-Jürgen Möller; Rolf Engel; Peter Falkai; Sermin Toto; Siegfried Kasper; Alexandra Neyazi
Journal:  Int J Neuropsychopharmacol       Date:  2018-09-01       Impact factor: 5.176

10.  Observing time effect of SSRIs on suicide risk and suicide-related behaviour: a network meta-analysis protocol.

Authors:  Qing-Hua Chen; Yu-Ling Li; Yi-Ru Hu; Wan-Yuan Liang; Bin Zhang
Journal:  BMJ Open       Date:  2021-12-07       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.